US 12208093
Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)
granted A61KA61K2300/00A61K31/4745
Quick answer
US patent 12208093 (Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)) held by THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jan 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K2300/00, A61K31/4745, A61K31/522, A61K38/05